Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia to Treatment of Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Dasatinib: From Treatment of Imatinib-Resistant or -Intolerant Patients With Chronic Myeloid Leukemia to Treatment of Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Published:2012-02 Issue:2 Volume:34 Page:272-281
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Abbott Brian L.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference58 articles.

1. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O'Brien;N Engl J Med,2003

2. International Randomized Study of Interferon vs STI571 (IRIS) 8-year follow up: sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib;Deininger;Blood,2009

3. A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trials;Lucas;Leukemia,2008

4. Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis;de Lavallade;J Clin Oncol,2008

5. Chronic myeloid leukemia: mechanisms of resistance and treatment;Jabbour;Hematol Oncol Clin North Am,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule-regulated switches to provide functional control of CAR T cells within the patient;Expert Opinion on Biological Therapy;2024-06-02

2. Landscape of extracellular vesicles in the tumour microenvironment: Interactions with stromal cells and with non-cell components, and impacts on metabolic reprogramming, horizontal transfer of neoplastic traits, and the emergence of therapeutic resistance;Seminars in Cancer Biology;2021-09

3. Synthesis and Molecular Docking Studies of Triazole Conjugated Novel 2,4-Disubstituted Thiazole Derivatives as CDK2 Inhibitors;Asian Journal of Chemistry;2021

4. Examining the Early Period Effect of Nilotinib on Hearing: An Experimental Study;The Journal of International Advanced Otology;2020-04-07

5. The efficacy of tolvaptan in treating dasatinib-induced pleural effusions in patients with chronic myelogenous leukemia;Journal of Cardiology;2020-02